| Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients C Ferri, G Valentini, F Cozzi, M Sebastiani, C Michelassi, G La Montagna, ... Medicine 81 (2), 139-153, 2002 | 1000 | 2002 |
| Genotype-driven phase I study of irinotecan administered in combination with fluorouracil/leucovorin in patients with metastatic colorectal cancer G Toffoli, E Cecchin, G Gasparini, M D'Andrea, G Azzarello, U Basso, ... Journal of clinical oncology 28 (5), 866-871, 2010 | 200 | 2010 |
| Cisplatin, dacarbazine with or without subcutaneous interleukin-2, and interferon alfa-2b in advanced melanoma outpatients: results from an Italian multicenter phase III … R Ridolfi, V Chiarion-Sileni, M Guida, A Romanini, R Labianca, A Freschi, ... Journal of Clinical Oncology 20 (6), 1600-1607, 2002 | 169 | 2002 |
| Extrapulmonary small cell carcinoma: a single-institution experience and review of the literature GL Re, V Canzonieri, A Veronesi, V Dal Bo, L Barzan, C Zancanaro, ... Annals of Oncology 5 (10), 909-913, 1994 | 137 | 1994 |
| 5-Aza-2'-deoxycytidine (Decitabine) induces trilineage response in unfavourable myelodysplastic syndromes V Zagonel, GL Re, G Marotta, R Babare, G Sardeo, V Gattei, V De Angelis, ... Leukemia 7, 30-35, 1993 | 135 | 1993 |
| Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer E Bajetta, I Floriani, M Di Bartolomeo, R Labianca, A Falcone, ... Annals of oncology 25 (7), 1373-1378, 2014 | 106 | 2014 |
| Clinical validity of a DPYD‐based pharmacogenetic test to predict severe toxicity to fluoropyrimidines G Toffoli, L Giodini, A Buonadonna, M Berretta, A De Paoli, S Scalone, ... International journal of cancer 137 (12), 2971-2980, 2015 | 95 | 2015 |
| Can type C hepatitis infection be complicated by malignant lymphoma? C Ferri, LL Civita, M Monti, G Longombardo, F Greco, G Pasero, ... The Lancet 346 (8987), 1426-1427, 1995 | 95 | 1995 |
| Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real‐world results from an expanded access programme U De Giorgi, G Cartenì, D Giannarelli, U Basso, L Galli, E Cortesi, ... BJU international 123 (1), 98-105, 2019 | 77 | 2019 |
| Quality of life evaluation in a randomised trial of chemotherapy versus bio-chemotherapy in advanced melanoma patients V Chiarion-Sileni, P Del Bianco, GL De Salvo, GL Re, A Romanini, ... European Journal of Cancer 39 (11), 1577-1585, 2003 | 69 | 2003 |
| Osteonecrosis of the jaw in patients with metastatic renal cell cancer treated with bisphosphonates and targeted agents: results of an Italian multicenter study and review of … V Fusco, C Porta, G Saia, C Paglino, G Bettini, M Scoletta, R Bonacina, ... Clinical Genitourinary Cancer 13 (4), 287-294, 2015 | 63 | 2015 |
| Preoperative assessment of peritoneal carcinomatosis in patients undergoing hyperthermic intraperitoneal chemotherapy following cytoreductive surgery EM Pasqual, S Bertozzi, S Bacchetti, AP Londero, SMM Basso, ... Anticancer research 34 (5), 2363-2368, 2014 | 60 | 2014 |
| Molecular characterisation of a field strain of bubaline herpesvirus isolated from buffaloes (Bubalus bubalis ) after pharmacological reactivation E De Carlo, GN Re, R Letteriello, V Del Vecchio, MP Giordanelli, ... Veterinary Record 154 (6), 171-174, 2004 | 51 | 2004 |
| Different distribution of antimicrobial resistance genes and virulence profiles of Staphylococcus aureus strains isolated from clinical mastitis in six countries V Monistero, A Barberio, F Biscarini, P Cremonesi, B Castiglioni, ... Journal of dairy science 103 (4), 3431-3446, 2020 | 46 | 2020 |
| Central nervous system metastases from castration-resistant prostate cancer in the docetaxel era O Caffo, A Gernone, C Ortega, T Sava, G Cartenì, G Facchini, GL Re, ... Journal of neuro-oncology 107, 191-196, 2012 | 46 | 2012 |
| Potentiation of thein vitro activity of some antimicrobial agents against selected Gram-negative bacteria by EDTA-tromethamine AM Farca, P Nebbia, G Re Veterinary research communications 17, 77-84, 1993 | 39 | 1993 |
| Canine dilated cardiomyopathy: Lymphocyte and cardiac α1-and β-adrenoceptor concentrations in normal and affected great danes G Re, L Bergamasco, P Badino, M Borgarelli, R Odore, A Tarducci, ... The Veterinary Journal 158 (2), 120-127, 1999 | 38 | 1999 |
| Feasibility and outcome of interval debulking surgery (IDS) after carboplatin-paclitaxel-bevacizumab (CPB): a subgroup analysis of the MITO-16A-MaNGO OV2A phase 4 trial G Daniele, D Lorusso, G Scambia, SC Cecere, MO Nicoletto, E Breda, ... Gynecologic Oncology 144 (2), 256-259, 2017 | 37 | 2017 |
| Local neurotoxicity after intra-arterial cisplatin in head and neck cancer. S Frustaci, L Barzan, R Comoretto, S Tumolo, S Monfardini Cancer treatment reports 71 (3), 257-259, 1987 | 36 | 1987 |
| Phosphatidylserine (PS) as a potential nutraceutical for canine brain aging: a review MC Osella, G Re, P Badino, L Bergamasco, A Miolo Journal of Veterinary Behavior 3 (2), 41-51, 2008 | 35 | 2008 |
